Iskon Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Faridabad, Haryana, India, established in 2022.
2022 Faridabad, Haryana, India Active
Last Updated:
Access Report
About Iskon Pharmaceuticals Private Limited

Iskon Pharmaceuticals Private Limited, a active private limited company, was established on 17 January 2022 in Faridabad, Haryana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24100HR2022PTC100589. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mohit Dakoria (Director), Murari Kumar Jha (Director). It is based at Plot No. 1314, Sector -64, Ballabgarh, Faridabad, Haryana, 121004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100HR2022PTC100589

  • Registration Number

    100589

  • Incorporation Date

    17 January 2022

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 29 Days
Company report

Iskon Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Iskon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Iskon Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohit Dakoria Director 17 Jan 2022 Current
Murari Kumar Jha Director 17 Jan 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Iskon Pharmaceuticals.

Enhance accessibility to Iskon Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Iskon Pharmaceuticals revenue growth over time
Iskon Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Iskon Pharmaceuticals?

Unlock access to Iskon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Iskon Pharmaceuticals?

Iskon Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iskon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iskon Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Iskon Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Mohit Dakoria was appointed as a Director was appointed as a Director on 17 Jan 2022 & has been associated with this company since 4 years 29 days . was documented.

  • Director Appointment

    Progress on Murari Kumar Jha was appointed as a Director was appointed as a Director on 17 Jan 2022 & has been associated with this company since 4 years 29 days . was documented.

  • Company Incorporation

    Progress on Iskon Pharmaceuticals Private Limited was registered on 17 Jan 2022 with Roc Delhi & aged 4 years 29 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Iskon Pharmaceuticals Private Limited?

The CIN of Iskon Pharmaceuticals Private Limited is U24100HR2022PTC100589.

Where is Iskon Pharmaceuticals Private Limited headquartered?

Iskon Pharmaceuticals Private Limited is headquartered at Plot No. 1314, Sector -64, Ballabgarh, Faridabad, Haryana, 121004.

When was Iskon Pharmaceuticals Private Limited incorporated?

Iskon Pharmaceuticals Private Limited was incorporated on 17 January 2022.

Who are the current directors of Iskon Pharmaceuticals Private Limited?

The current directors of Iskon Pharmaceuticals Private Limited are

What is the primary industry of Iskon Pharmaceuticals Private Limited?

The primary industry of Iskon Pharmaceuticals Private Limited is Chemicals.

Is Iskon Pharmaceuticals Private Limited a listed company?

Iskon Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Iskon Pharmaceuticals Private Limited?

The authorized capital of Iskon Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available